KZR
Kezar Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.29
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+15.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 3, 2025 | Chiang Pichi Luo · officer: SVP, Corporate Controller | Sale | 264 | $4.28 |
| Jul 3, 2025 | Schiller Mark C. · officer: Chief Operating Officer | Sale | 561 | $4.28 |
| Jul 1, 2025 | To Zung Phuong · officer: Chief Development Officer | A-Award | 7,000 | $4.40 |
| Jun 23, 2025 | Klearman Micki · director | A-Award | 5,000 | $4.46 |
| Jun 23, 2025 | Kauffman Michael · director | A-Award | 5,000 | $4.46 |
| Jun 23, 2025 | Wallace Courtney · director | A-Award | 5,000 | $4.46 |
| Jun 23, 2025 | Garner Elizabeth · director | A-Award | 5,000 | $4.46 |
| Jun 23, 2025 | COOPER GRAHAM K · director | A-Award | 5,000 | $4.46 |
| Jun 23, 2025 | BERGER FRANKLIN M · director | A-Award | 5,000 | $4.46 |
| Jun 23, 2025 | Fowler John Franklin · director | A-Award | 5,000 | $4.46 |
| Apr 1, 2025 | Schiller Mark C. · officer: Chief Legal Officer | A-Award | 4,800 | $6.30 |
| Apr 1, 2025 | Belsky Marc · officer: Chief Financial Officer | A-Award | 4,800 | $6.30 |
| Mar 5, 2025 | Belsky Marc · officer: Chief Financial Officer | A-Award | 7,200 | $6.30 |
| Mar 5, 2025 | Schiller Mark C. · officer: Chief Legal Officer | A-Award | 7,200 | $6.30 |
| Feb 14, 2025 | Fowler John Franklin · director | A-Award | 5,000 | $5.89 |
| Jan 13, 2025 | Schiller Mark C. · officer: Chief Legal Officer | A-Award | 24,500 | $6.58 |
| Jan 13, 2025 | Belsky Marc · officer: Chief Financial Officer | A-Award | 24,500 | $6.58 |
| Jan 13, 2025 | Kirk Christopher J. · director, officer: CEO | A-Award | 120,000 | $6.58 |
| Jul 26, 2024 | Schiller Mark C. · officer: Chief Legal Officer | Sale | 6,688 | $0.58 |
| Jun 21, 2024 | Garner Elizabeth · director | A-Award | 50,000 | $0.67 |
| Jun 21, 2024 | Wallace Courtney · director | A-Award | 50,000 | $0.67 |
| Jun 21, 2024 | COOPER GRAHAM K · director | A-Award | 50,000 | $0.67 |
| Jun 21, 2024 | Klearman Micki · director | A-Award | 50,000 | $0.67 |
| Jun 21, 2024 | Kauffman Michael · director | A-Award | 50,000 | $0.67 |
| Jun 21, 2024 | BERGER FRANKLIN M · director | A-Award | 50,000 | $0.67 |
| Jan 9, 2024 | Belsky Marc · officer: Chief Financial Officer | A-Award | 295,000 | $0.93 |
| Jan 9, 2024 | Mordwinkin Nicholas Michael · officer: Chief Business Officer | A-Award | 275,000 | $0.93 |
| Nov 9, 2023 | Kirk Christopher J. · director, officer: CEO | A-Award | 875,000 | $0.84 |
| Jul 26, 2023 | Wallace Courtney · director | A-Award | 52,000 | $2.28 |
| Jul 26, 2023 | Wallace Courtney · director | A-Award | 26,000 | $2.28 |
Institutional positioning
13F filings over the trailing two quarters
New 13Increased 9Reduced 9Sold out 44
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | Unchanged | 720,787 | May 6, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 716,759 | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 664,314 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 290,529 | May 15, 2026 |
| RANGELEY CAPITAL, LLC | Increased | 243,073 | May 15, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Unchanged | 229,076 | May 14, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 201,600 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 188,426 | May 14, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 151,630 | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | New Position | 142,050 | May 15, 2026 |
| PEAPOD LANE CAPITAL LLC | Reduced | 126,692 | May 4, 2026 |
| IKARIAN CAPITAL, LLC | Unchanged | 102,211 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 100,064 | May 13, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | Reduced | 81,933 | May 18, 2026 |
| GROUPE LA FRANCAISE | New Position | 80,400 | May 21, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 3, 2025